Immuron (IMRN) Prepaid Assets (2016 - 2025)
Immuron (IMRN) posted quarterly Prepaid Assets of $34867.4 for Q3 2025, up 3500.48% year-on-year from $968.41 in Q3 2024, and down 98.58% on a QoQ basis from $2.5 million in Q2 2025.
Immuron (IMRN) Prepaid Assets (2016 - 2025) Analysis & Trends
Immuron (IMRN) has reported Prepaid Assets for 10 consecutive years, with $34867.4 the latest figure, recorded in Q3 2025.
- Quarterly Prepaid Assets rose 3500.48% year-over-year to $34867.4 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $34867.4 (up 3500.48% YoY) and the FY2025 annual result came in at $34867.4, up 3500.48% from the prior year.
- Prepaid Assets slipped to $34867.4 in Q3 2025 per IMRN's latest filing, from $2.5 million in the prior quarter.
- Over the last five years, Prepaid Assets for IMRN reached as high as $2.5 million in Q2 2025 and fell as low as $968.41 in Q3 2024.
- A 5-year average of $310572.9 and a median of $90040.8 in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets sank 99.61% — and 2024, when it jumped 7381.22%.
- Year by year, Prepaid Assets stood at $55267.7 in 2021, then surged by 631.43% to $404243.0 in 2022, then sank by 99.39% to $2462.4 in 2023, then soared by 7381.22% to $184218.7 in 2024, then tumbled by 81.07% to $34867.4 in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $34867.4, $2.5 million, and $184218.7 for Q3 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 34,867.44 |
| Jun 30, 2025 | 2.46 Mn |
| Dec 31, 2024 | 184,218.71 |
| Sep 9, 2024 | 968.41 |
| Jun 30, 2024 | 68,391.50 |
| Dec 31, 2023 | 2,462.41 |
| Sep 28, 2023 | 111,690.14 |
| Aug 30, 2023 | 1,581.51 |
| Jun 30, 2023 | 158,151.00 |
| Dec 31, 2022 | 404,243.00 |
| Aug 31, 2022 | 404,243.00 |
| Jun 30, 2022 | 404,243.00 |
| Dec 31, 2021 | 55,267.73 |
| Jun 30, 2021 | 55,267.73 |
| Dec 31, 2020 | 1,631.98 |
| Sep 1, 2020 | 33,194.00 |
| Jun 30, 2020 | 23,442.42 |
| Dec 31, 2019 | 331.94 |
| Jun 30, 2019 | 49,290.00 |
| Dec 31, 2018 | 141,800.00 |